Top 6 Pharma Social Media Break Through in 2019
Bio Spectrum|February 2020
In a relatively short period of time, social media has reshaped communication for consumers and healthcare professionals alike.
Ankit Kankar
Top 6 Pharma Social Media Break Through in 2019

No longer are users simply posting content and communicating amongst themselves. Social channels are now dominated by media reaching specifically targeted audiences.

Looking forward to what lies ahead in the social space, have a look at the top social media trends for pharma in 2019 based on innovation, growth, and opportunities.

6 Cleaned up Twitter name

Pfizer cleaned up its Twitter name earlier by acquiring the rights to @pfizer, which replaced the somewhat awkward @pfizer_news handle it had been using for its official Twitter presence since joining the platform in 2009. Years ago, the company was too late in the Twitter game to register its own name, which had already been taken. Now, with the name reclaimed, tweets from @pfizer really are resulting in a gain of interactions and followers that are more than 250K in number.

5 Made record views on YouTube

http://www.youtube.com/user/JNJhealth

Johnson & Johnson has provided many social media firsts in the past, and here’s one that comes after years of pioneering engagement: in 2019, the total number of video views on the company’s YouTube channel exceeded 22 801 417 views.

هذه القصة مأخوذة من طبعة February 2020 من Bio Spectrum.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة February 2020 من Bio Spectrum.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من BIO SPECTRUM مشاهدة الكل
Economic Survey Lays Focus On Mental Healthcare For The First Time
Bio Spectrum

Economic Survey Lays Focus On Mental Healthcare For The First Time

For the first time ever, the Economic Survey 2023-24 tabled by the Union Minister of Finance and Corporate Affairs Nirmala Sitharaman in Parliament recently, talks extensively about mental health, its significance and implications on policy recommendations.

time-read
1 min  |
September 2024
IIT-G discovers RNA-destroying function of p30 protein in African Swine Fever Virus
Bio Spectrum

IIT-G discovers RNA-destroying function of p30 protein in African Swine Fever Virus

Indian Institute of Technology Guwahati (IIT-G) researchers have investigated the biochemistry of the African Swine Fever Virus (ASFV) protein, focusing on understanding the biochemical processes of infection to devise effective control strategies.

time-read
1 min  |
September 2024
13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors
Bio Spectrum

13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors

The 13th edition of Bengaluru INDIA NANO 2024, organised by the Department of Science & Technology, Government of Karnataka, Karnataka Science & Technology Promotion Society (KSTePS), and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) concluded on August 3 with participation of 1018 delegates, 11 countries including Korea, Morocco, USA, UK, France, Canada, Germany, Netherlands, Russia, Japan, and Poland, 49 exhibitors comprising 21 startups and 28 industry and institutes, and 200 posters. The exhibition had a footfall of 3,000+ visitors.

time-read
3 mins  |
September 2024
Are Nutraceuticals DRUGS? Examining a Needless Regulatory Tussle
Bio Spectrum

Are Nutraceuticals DRUGS? Examining a Needless Regulatory Tussle

The news has been around for a while which has put a big question mark ahead of the Indian nutraceuticals industry.

time-read
9 mins  |
September 2024
Can India Reclaim API Throne from China?
Bio Spectrum

Can India Reclaim API Throne from China?

Despite having the third-largest pharmaceutical industry by volume in the world and being the largest manufacturer of generic medicines globally, India is heavily dependent on China for imports of raw materials, Key Starting Materials (KSMs), and Active Pharmaceutical Ingredients (APIs).

time-read
10+ mins  |
September 2024
JRS Pharma & Gujarat Microwax open new manufacturing facility in Mehsana
Bio Spectrum

JRS Pharma & Gujarat Microwax open new manufacturing facility in Mehsana

JRS Pharma, a leading manufacturer of excipients, in partnership with Gujarat Microwax, has commissioned a new manufacturing facility for cotton-based croscarmellose sodium.

time-read
1 min  |
September 2024
NovaLead's patented repurposed drug for treating DFU gets CDSCO approval
Bio Spectrum

NovaLead's patented repurposed drug for treating DFU gets CDSCO approval

Pune-based NovaLead Pharma has announced that the drug regulator in India, Central Drugs Standard Control Organisation (CDSCO), has approved their patented Repurposed Drug for treatment of Diabetic Foot Ulcer (DFU) which is a global unmet medical need.

time-read
1 min  |
September 2024
Medicamen Organics expands footprint in East Africa with $75,000 investment in Rwanda
Bio Spectrum

Medicamen Organics expands footprint in East Africa with $75,000 investment in Rwanda

Delhi-based pharma company Medicamen Organics has taken a significant step in its global expansion strategy by signing a Memorandum of Understanding (MoU) with Depot Pharmacy Yego in Rwanda.

time-read
1 min  |
September 2024
Mankind Pharma acquires 100% stake in Bharat Serums and Vaccines for Rs 13,630 Cr
Bio Spectrum

Mankind Pharma acquires 100% stake in Bharat Serums and Vaccines for Rs 13,630 Cr

Mankind Pharma has entered into a definitive agreement to acquire a 100 per cent stake in Bharat Serums and Vaccines Limited (BSV) from Advent International, for an enterprise value of approx.

time-read
1 min  |
September 2024
Thyrocare buys Polo Labs' pathology diagnostic biz to strengthen Northern India presence
Bio Spectrum

Thyrocare buys Polo Labs' pathology diagnostic biz to strengthen Northern India presence

Mumbai-based Thyrocare, a leading diagnostic and preventive healthcare service provider in India, has entered into a Business Transfer Agreement with Polo Labs to acquire their pathology diagnostic business.

time-read
1 min  |
September 2024